Tasquinimod Completed Phase 2 Trials for Advanced or Metastatic Gastric Carcinoma / Advanced or Metastatic Hepatocellular Cancer / Metastatic Renal Cell Cancer / Advanced or Metastatic Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01743469A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers